MLXIPL and metabolic dysfunction-associated steatotic liver disease: Moreover, AMPK and its regulated genes including SREBP and ChREBP were involved in the regulation of metabolic disorders such as hyperglycemia, hypercholesterolemia, hyeruricemia that is associated with kidney diseases, cardiovascular disease, and NAFLD.